Iowa City, IA, United States of America

Matthew Mcneill

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Matthew Mcneill

Introduction

Matthew Mcneill is an accomplished inventor based in Iowa City, IA (US). He has made significant contributions to the field of genetic research, particularly in the area of CRISPR technology. His work focuses on improving the accuracy of DNA break repair identification and characterization.

Latest Patents

Matthew holds a patent titled "Identification, characterization, and quantitation of CRISPR-introduced double-stranded DNA break repairs." This patent describes a system and process for identifying and characterizing double-stranded DNA break repair sites based on biological information, resulting in improved accuracy. Additionally, it outlines a sequence alignment process that utilizes biological data to enhance the alignment matrix for position-specific alignment scoring, which aids in identifying noncanonical target sites.

Career Highlights

Matthew is currently employed at Integrated DNA Technologies, Inc., where he continues to advance his research in genetic engineering. His innovative approach has garnered attention in the scientific community, contributing to the ongoing evolution of CRISPR technology.

Collaborations

Matthew has collaborated with notable colleagues, including Heng Li and Gavin Kurgan. Their combined expertise has furthered the development of groundbreaking techniques in DNA research.

Conclusion

Matthew Mcneill's contributions to the field of genetic research, particularly through his patent on CRISPR technology, highlight his role as a leading inventor in this innovative area. His work continues to pave the way for advancements in genetic engineering and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…